Leadership Overview
Pierre Fabre has 7 executives leading key functions including financial strategy, operational coordination, regional fiscal management, dermo-cosmetics development, and human resources.
Focused on advancing global health and beauty standards, Pierre Fabre delivers innovative pharmaceutical and dermo-cosmetic solutions while maintaining a commitment to scientific excellence and sustainable market growth across international territories.
Focused on advancing global health and beauty standards, Pierre Fabre delivers innovative pharmaceutical and dermo-cosmetic solutions while maintaining a commitment to scientific excellence and sustainable market growth across international territories.
Leadership Roles at Pierre Fabre
Venaig Solinhac - Chief Executive Officer, Dermo-Cosmetics & Personal Care division
Venaig Solinhac, the Chief Executive Officer, Dermo-Cosmetics & Personal Care division at Pierre Fabre, directs the global strategy and product development for the dermo-cosmetics portfolio, including the flagship Eau Thermale Avène brand. Overseeing the entire division, the Chief Executive Officer, Dermo-Cosmetics & Personal Care division drives innovation in skincare solutions to meet the needs of diverse consumer demographics across Europe and Asia. This leadership role involves managing the lifecycle of premium cosmetic products and ensuring that scientific research translates into market-leading offerings. By expanding the global footprint of the division, Venaig Solinhac secures significant market share and brand loyalty. The Chief Executive Officer, Dermo-Cosmetics & Personal Care division collaborates with research teams to maintain the highest standards of product efficacy and safety. Through strategic brand positioning, the Chief Executive Officer, Dermo-Cosmetics & Personal Care division sustains the growth and reputation of the company in the global beauty industry.

Ewart Toit - Chief Financial Officer
Ewart Toit, the Chief Financial Officer at Pierre Fabre, manages the global fiscal health and capital allocation strategies for the entire pharmaceutical and dermo-cosmetics enterprise. Overseeing long-term financial planning, the Chief Financial Officer ensures the company maintains robust liquidity to support research and development initiatives. This leadership role involves rigorous oversight of budgetary compliance and risk management across all international business units. By optimizing the capital structure, Ewart Toit directly impacts the ability of the organization to scale production and expand market reach. The Chief Financial Officer collaborates with the board to align fiscal objectives with the broader mission of delivering high-quality healthcare products. Through precise financial modeling and performance analysis, the Chief Financial Officer secures the economic stability required for sustained innovation in the competitive global pharmaceutical landscape.
Amanda de Lima Ventura - Chief Financial Officer (Brazil)
Amanda de Lima Ventura, the Chief Financial Officer (Brazil) at Pierre Fabre, directs all fiscal operations and financial reporting within the critical South American market. Overseeing regional revenue streams, the Chief Financial Officer (Brazil) ensures strict adherence to local regulatory requirements while supporting the expansion of the dermo-cosmetics portfolio. This leadership role involves managing local investment strategies and optimizing cost structures to maximize profitability in a high-growth environment. By analyzing regional market trends, Amanda de Lima Ventura provides the insights necessary for the company to maintain a competitive edge in the Brazilian pharmaceutical sector. The Chief Financial Officer (Brazil) collaborates with global finance teams to integrate regional performance data into the broader corporate strategy. Through disciplined financial oversight, the Chief Financial Officer (Brazil) strengthens the market position of the company, ensuring consistent growth and operational excellence across the entire South American region.
Marcela Pacobahyba - Chief of Staff
Marcela Pacobahyba, the Chief of Staff at Pierre Fabre, coordinates cross-functional operations and streamlines communication between executive leadership and departmental heads. Managing the strategic agenda, the Chief of Staff ensures that organizational priorities remain aligned with the core mission of the pharmaceutical and dermo-cosmetics divisions. This role involves facilitating high-level decision-making processes and monitoring the execution of corporate initiatives across global markets. By fostering collaboration among diverse teams, Marcela Pacobahyba drives operational efficiency and organizational agility. The Chief of Staff translates complex business objectives into actionable tasks, ensuring that the executive team maintains focus on long-term growth and market leadership. Through proactive management of internal workflows, the Chief of Staff optimizes the performance of the entire corporate structure, enabling the company to respond effectively to evolving industry demands and consumer health needs.
Paulo Ferraz - Country Chief Finance Officer
Paulo Ferraz, the Country Chief Finance Officer at Pierre Fabre, directs the financial operations and fiscal compliance for specific national markets, ensuring that local business units meet corporate profitability targets. Overseeing regional accounting and tax strategies, the Country Chief Finance Officer supports the growth of the pharmaceutical and dermo-cosmetics business by providing accurate financial data and risk assessments. This leadership role involves managing local cash flow and optimizing resource allocation to support regional sales and marketing efforts. By monitoring the financial performance of the country-level operations, Paulo Ferraz provides the insights necessary for the company to adapt to local market conditions. The Country Chief Finance Officer collaborates with the global finance team to ensure consistency in reporting and strategic alignment. Through rigorous financial management, the Country Chief Finance Officer secures the economic viability of the company in key markets, driving long-term value creation.
Yann Dugenou - Drh
Yann Dugenou, the Drh at Pierre Fabre, architects the human capital strategy and talent management framework to support the global pharmaceutical and dermo-cosmetics workforce. Overseeing organizational development, the Drh ensures that the company attracts and retains top-tier scientific and commercial talent. This leadership role involves designing comprehensive training programs and fostering a culture of innovation and professional growth. By aligning workforce capabilities with the strategic goals of the company, Yann Dugenou drives productivity and employee engagement across all international operations. The Drh collaborates with executive leadership to implement performance management systems that reward excellence and support the long-term mission of the organization. Through effective talent acquisition and development initiatives, the Drh strengthens the internal capacity of the company, ensuring that the workforce remains equipped to tackle the complex challenges of the modern pharmaceutical and dermo-cosmetics market.
Kamel Khlifati - Drh
Kamel Khlifati, the Drh at Pierre Fabre, manages labor relations and internal corporate culture to ensure operational stability across the manufacturing and research facilities. Overseeing employee welfare and workplace safety, the Drh implements policies that promote a high-performance environment within the pharmaceutical and dermo-cosmetics divisions. This leadership role involves navigating complex labor regulations and fostering inclusive practices that support a diverse global workforce. By optimizing internal communication channels, Kamel Khlifati ensures that all staff members remain aligned with the core values and strategic objectives of the company. The Drh collaborates with department heads to address staffing needs and enhance operational efficiency through improved human resource processes. Through dedicated focus on employee development and organizational health, the Drh supports the overall mission of the company, ensuring that the workforce remains a key driver of success in the competitive global healthcare landscape.
Explore Leadership Teams in Manufacturing
Fresenius Kabi, a subsidiary of Fresenius, is a global health care company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is headquartered in Bad Homburg, Germany with locations around the world.
Company Leadership SM
RT

Sarepta Therapeutics, Inc. is a global commercial-stage biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts. The company is focused on the discovery, development, and commercialization of precision genetic medicines for rare diseases, with particular leadership in Duchenne muscular dystrophy and limb-girdle muscular dystrophies. Sarepta's multi-platform Precision Genetic Medicine Engine spans gene therapy, RNA-targeted therapeutics, and gene editing modalities. The company holds multiple FDA-approved treatments and maintains a broad pipeline of programs across neuromuscular and central nervous system disorders. Sarepta operates globally with locations across North America, Europe, and Asia, and trades on the NASDAQ under the ticker symbol SRPT.
Company Leadership
AN

ZG
Humanetics Corporation is a clinical-stage pharmaceutical company engaged in the accelerated discovery, development, and commercialization of proprietary drugs in markets with urgent and unmet needs with a focus on medical countermeasures, radiation modulators for oncology and inflammatory lung diseases.
Company Leadership BL
KN
SC
AS
Founded in 1994 and headquartered in Shanghai, China, Fosun Pharma is a company that focuses on the research and development and manufacturing of pharmaceuticals.
Company Leadership YB
YS
AH